University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Anticholinergic burden in middle-aged women and recurrent falls in later life : findings from the Aberdeen Prospective Osteoporosis Screening Study (APOSS)

Simple item page
dc.contributor.authorNeal, Samuel R.
dc.contributor.authorWood, Adrian D.
dc.contributor.authorAblett, Andrew D.
dc.contributor.authorGregory, Jenny S.
dc.contributor.authorGuillot, Jordan
dc.contributor.authorMacdonald, Helen M.
dc.contributor.authorReid, David M.
dc.contributor.authorMyint, Phyo Kyaw
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Medical Educationen
dc.contributor.institutionUniversity of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH)en
dc.contributor.institutionUniversity of Aberdeen.Applied Medicineen
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.date.accessioned2020-06-16T12:00:01Z
dc.date.available2020-06-16T12:00:01Z
dc.date.issued2020
dc.descriptionACKNOWLEDGEMENTS AND FUNDING The Aberdeen Prospective Osteoporosis Screening Study (APOSS) was funded by the Grampian Osteoporosis Trust. SRN received an Aberdeen Summer Research Scholarship supported by funding from the Institute of Applied Health Sciences, University of Aberdeen, UK. The funder had no role in design, analysis, interpretation or reporting of the work presented. We gratefully acknowledge the Steering Committee of APOSS for their permission to conduct this research.en
dc.description.statusPeer revieweden
dc.format.extent9
dc.format.extent193335
dc.identifier162463165
dc.identifier6ee2aa12-2442-458c-bf61-dba35579e866
dc.identifier85085623757
dc.identifier32547728
dc.identifier.citationNeal, S R, Wood, A D, Ablett, A D, Gregory, J S, Guillot, J, Macdonald, H M, Reid, D M & Myint, P K 2020, 'Anticholinergic burden in middle-aged women and recurrent falls in later life : findings from the Aberdeen Prospective Osteoporosis Screening Study (APOSS)', Therapeutic Advances in Drug Safety, vol. 11, pp. 1-9. https://doi.org/10.1177/2042098620929852en
dc.identifier.doi10.1177/2042098620929852
dc.identifier.issn2042-0986
dc.identifier.otherPubMedCentral: PMC7273562
dc.identifier.otherORCID: /0000-0003-3852-6158/work/163198620
dc.identifier.urihttps://hdl.handle.net/2164/14508
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85085623757&partnerID=8YFLogxKen
dc.identifier.vol11en
dc.language.isoeng
dc.relation.ispartofTherapeutic Advances in Drug Safetyen
dc.subjectAccidental Fallsen
dc.subjectCholinergic Antagonistsen
dc.subjectMiddle Ageden
dc.subjectPolypharmacyen
dc.subjectaccidental fallsen
dc.subjectcholinergic antagonistsen
dc.subjectmiddle ageden
dc.subjectpolypharmacyen
dc.subjectR Medicine (General)en
dc.subjectPharmacology (medical)en
dc.subject.lccR1en
dc.titleAnticholinergic burden in middle-aged women and recurrent falls in later life : findings from the Aberdeen Prospective Osteoporosis Screening Study (APOSS)en
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Neal_etal_TADS_Anticholinergic_VOR.pdf
Size:
188.8 KB
Format:
Adobe Portable Document Format
Download

Collections

All research